SCHEMBL2701263

SCHEMBL2701263

N#Cc1ccc(N2CCC[C@@]3(CCN(C4CCOCC4)C3=O)C2)c(F)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A9 P48067 6/20 0.39
ALK Q9UM73 1/20 0.39
SLC6A5 Q9Y345 2/20 0.38
HSD11B1 P28845 2/20 0.37
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HCRTR1 O43613 1/20 0.35
HCRTR2 O43614 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4A P27815 1/20 0.35
PTH1R Q03431 2/20 0.34
OPRM1 P35372 1/20 0.34
OPRL1 P41146 1/20 0.34
CHRM4 P08173 1/20 0.34
PRKDC P78527 1/20 0.34
HTR7 P34969 1/20 0.34
ADRA1D P25100 1/20 0.34
ADRA1A P35348 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL550885 1.00 SLC6A9 (0.39) SLC6A9ALKSLC6A5HSD11B1KDM4E
SCHEMBL549286 0.91 HSD11B1 (0.45) SLC6A9ALKHSD11B1KDM4EALDH1A1
SCHEMBL550162 0.89 SLC6A9 (0.38) SLC6A9HSD11B1KDM4EALDH1A1MAPT
SCHEMBL4559472 0.89 HSD11B1 (0.40) ALKHSD11B1KDM4EALDH1A1MAPT
SCHEMBL550161 0.89 SLC6A9 (0.38) SLC6A9HSD11B1KDM4EALDH1A1MAPT
SCHEMBL549494 0.89 HSD11B1 (0.40) ALKHSD11B1KDM4EALDH1A1MAPT
SCHEMBL2699850 0.89 HSD11B1 (0.40) ALKHSD11B1KDM4EALDH1A1MAPT
SCHEMBL2699416 0.83 HSD11B1 (0.40) HSD11B1ALDH1A1MAPTSMN1; SMN2HTR7
SCHEMBL550765 0.83 HSD11B1 (0.40) HSD11B1ALDH1A1MAPTSMN1; SMN2HTR7
SCHEMBL5572384 0.81 HSD11B1 (0.39) HSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2450351-A1 Lactam compounds and their use as pharmaceuticals Incyte Corporation (US) 2012-05-09 EP claimed
EP-1812005-A2 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS Incyte Corporation (US) 2007-08-01 EP claimed
WO-2006053024-A2 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2006-05-18 WO claimed
EP-1812005-B1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORP (US) 2015-09-16 EP disclosed
EP-1812005-B1 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORP (US) 2015-09-16 EP disclosed
EP-2450351-A1 Lactam compounds and their use as pharmaceuticals Incyte Corporation (US) 2012-05-09 EP disclosed
EP-1812005-A2 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS Incyte Corporation (US) 2007-08-01 EP disclosed
US-20060116382-A1 Lactam compounds and their use as pharmaceuticals INCYTE CORPORATION 2006-06-01 US disclosed
WO-2006053024-A2 LACTAM COMPOUNDS AND THEIR USE AS PHARMACEUTICALS INCYTE CORPORATION (US) 2006-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060116382-A1 Lactam compounds and their use as pharmaceuticals HSD11B1, HSD11B2, HSD17B1 SLC6A9 2337/4885ALK 3964/4885SLC6A5 2200/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.